Patent ID: 9423372
Filing Date: 2016-08-23
CPC Classification: G01N

Claim Text:
1. A method for determining the efficacy of a treatment for cardiovascular disease in a patient having a cardiovascular disease, wherein the oxidation-reduction potential (ORP) of a sample from the patient is higher than normals, the method comprising: a. administering the treatment for cardiovascular disease to the patient; b. following administration of the treatment, measuring the oxidation-reduction potential (ORP) of a body fluid and/or a tissue from the patient, by contacting an electrode with the body fluid or tissue of the patient, wherein the electrode is connected to a meter that provides a readout of the ORP; and c. determining if the ORP value of the body fluid and /or tissue from the patient is significantly different than an ORP value obtained prior to the treatment; wherein if the post-treatment ORP value is lower than the pre-treatment ORP value, maintaining the treatment; and wherein if the post-treatment ORP value is the same as, or greater than, the pre-treatment ORP value, administering a more aggressive, additional or different treatment to the patient.